Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes - Concepedia

Concepedia

Publication | Closed Access

Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

1.5K

Citations

30

References

2005

Year

Ralph A. DeFronzo, Robert E. Ratner, Jenny Han, Dennis Dong Hwan Kim, Mark Fineman, Alain Baron

Abstract

Exenatide was generally well tolerated and reduced HbA(1c) with no weight gain and no increased incidence of hypoglycemia in patients with type 2 diabetes failing to achieve glycemic control with metformin.

References

	Year	Citations

Page 1